6 completed. 3 Phase 3, 2 Phase 4, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
| Phase 4 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow this drug Literature Review of PsACWY vaccine trials Research Report on PsACWY vaccine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunogenicity and Safety of Meningococcal Vaccine GSK 134612 Versus Mencevax™ ACWY in Healthy 18-25 Year Olds Mencevax ACWY, GSK Biologicals' meningococcal serogroup A, C, W-135, Y tetanus toxoid conjugate investigational vaccine [GSK 134612] - Infections, Meningococcal | Phase 3 | Completed | GlaxoSmithKline | 1170 | 2010-08-27 | 2018-11-26 |
| Response to GSK Biologicals' Tritanrix-HepB/Hib-MenAC Vacc (4th Dose) at 15-24m & Mencevax ACWY at 24-30m Tritanrix-HepB/Hib-MenAC, Mencevax ACWY, Tritanrix-HepB/Hiberix - Whole Cell Pertussis, Haemophilus Influenzae Type b | Phase 3 | Completed | GlaxoSmithKline | 617 | 2006-01-22 | 2020-02-20 |
| Safety of Purified Meningococcal Vaccine With Serogroups ACWY, in 3,000 Filipino Subjects Aged > 2 Years Mencevax ACWY - Infections, Meningococcal | Phase 4 | Completed | GlaxoSmithKline | 249 | 2006-01-14 | 2018-06-08 |
| Study in Children to Evaluate the Immunogenicity and Safety of 4 Formulations of GSK Bio MenACWY-TT Conjugate Vaccine Conjugated meningococcal ACWY-TT (vaccine), DTPa/Hib containing vaccine, Meningitec - Infections, Meningococcal | Phase 2 | Completed | GlaxoSmithKline | 508 | 2005-07-01 | 2016-10-07 |
| Safety Study of Tritanrix-HepB/Hib-MenAC, Tritanrix-HepB/Hiberix, and Mencevax ACWY Vaccines in Children Tritanrix-HepB/Hib-MenAC, Tritanrix-HepB/Hiberix, Mencevax-ACWY - Whole Cell Pertussis, Tetanus | Phase 3 | Completed | GlaxoSmithKline | 798 | 2005-06-16 | 2020-02-20 |
| Assess the Non-inferiority of GSK Biologicals' Mencevax™ ACWY (Manufactured by a New Process) vs Mencevax™ ACWY (the Already Existing Vaccine in the Market) When Given as a Single Dose to Subjects Aged 2-30 Yrs Mencevax ACWY - Infections, Meningococcal | Phase 4 | Completed | GlaxoSmithKline | 324 | 2005-06-01 | 2016-09-21 |
Meningococcal Infections (4) · Diphtheria (2) · Haemophilus Infections (2) · Hepatitis B (2) · Tetanus (2)
GlaxoSmithKline (6)
Philippines (3) · Thailand (3) · Austria (1) · Germany (1) · Lebanon (1) · Panama (1)